Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women
Authors: Kayla HendricksonKathleen HurwitzKara Bennett
View publication →Solution
Target RWE's HIV team analyzed objective TDF/FTC adherence data from drug concentration measurements among HIV-exposed South African women during periconception, describing adherence levels, temporal patterns, and predictors.
Impact
Demonstrating objectively measured periconception PrEP adherence patterns provides HIV prevention partners with evidence of real-world adherence challenges, supporting adherence-enhancing intervention development.
Use Cases / Links
Objective PrEP adherence characterization during periconception in HIV-exposed South African women, Pharmacologic drug level evidence for PrEP adherence program design in high-HIV-incidence settings